Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

NCT06211036

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Infirmary Cancer Center Mobile, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
View all 219 locations
View Trial Details
Active, not recruiting

Lorlatinib Continuation Study

NCT05144997

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • The First affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Chest Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 27 locations
View Trial Details
Active, not recruiting

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT04625647

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations
  • Veterans Administration Medical Center - Birmingham Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 829 locations
View Trial Details
Active, not recruiting

Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC

NCT02259621

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Johns Hopkins at Bayview Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Memorial Sloan Kettering New York, United States
  • Swedish Cancer Insitute Edmonds, Washington, United States
View Trial Details
Active, not recruiting

Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations

NCT05103605

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Abbeville, France
  • Research Site Aix-en-Provence, France
  • Research Site Angers, France
  • Research Site Antibes, France
View all 46 locations
View Trial Details
Active, not recruiting

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.

NCT04823377

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • CH Abbeville Abbeville, France
  • CH du Pays d'Aix Aix-en-Provence, France
  • CHU Amiens - Hôpital Sud Amiens, France
  • CHU Angers Angers, France
View all 25 locations
View Trial Details

Related conditions